Quel est le prix pour Gamida Cell Ltd. (GMDA)

Le prix pour Gamida Cell Ltd. (GMDA) est $0.0327

Quelle est la capitalisation boursière pour Gamida Cell Ltd. (GMDA)

La capitalisation boursière pour Gamida Cell Ltd. (GMDA) est $4.34M

Gamida Cell Ltd. (GMDA) Prix et Capitalisation Boursière

Gamida Cell Ltd. operates as a clinical-stage biopharmaceutical firm, dedicated to pioneering cell therapies aimed at eradicating blood cancers and other severe hematological conditions. The company's leading investigational product, omidubicel—a specialized cell therapy—has successfully concluded its Phase III clinical evaluation for individuals afflicted with high-risk hematologic malignancies. Furthermore, it is currently undergoing Phase I/II trials for patients suffering from severe aplastic anemia. Another significant therapeutic candidate, GDA-201, an immunotherapy harnessing natural killer cells, is progressing through Phase I/II studies to address relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Beyond these, Gamida Cell is actively advancing a broader natural killer (NK) cell pipeline, which includes GDA-301, GDA-401, GDA-501, and GDA-601, with the ambition of treating both hematologic cancers and solid tumors. Founded in 1998, the company maintains its corporate headquarters in Jerusalem, Israel.

Prix pour GMDA	L’actif B	La capitalisation boursière de B	Résultats
$41,101.51 $4.34M	NVDA	$5.452T	+125,692,588.97%
$33,850.16 $4.34M	AAPL	$4.490T	+103,517,214.83%
$31,380.29 $4.34M	GOOG	$4.162T	+95,964,100.96%
$27,715.86 $4.34M	MSFT	$3.676T	+84,757,892.92%
$21,358.25 $4.34M	AMZN	$2.833T	+65,315,634.53%

Prix pour GMDA

L’actif B

La capitalisation boursière de B

Résultats

$41,101.51 $4.34M